Corbus Describes Phase 1 Results of ADC Trial for Bladder and Cervical Cancers by Technical Terrence Team 06/01/2024 0 free of law Corbus Pharmaceuticals (NASDAQ:CRBP) said its antibody-drug conjugate, CRB-701, demonstrated promising efficacy and safety data in a Phase ...